Gene silencing in skin after deposition of self-delivery siRNA with a motorized microneedle array device

Molecular Therapy Nucleic Acids

Volumn 2, Issue OCT, 2013, Pages e129-

  Hickerson, Robyn P ^a,b   Wey, Winston C ^c,d   Rimm, David L ^e   Speaker, Tycho ^a   Suh, Susie ^c   Flores, Manuel A ^a   Gonzalez Gonzalez, Emilio ^c,f   Leake, Devin ^g   Contag, Christopher H ^c   Kaspar, Roger L ^a  

^a TransDerm   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^g Thermo Fisher Scientific   (United States)

Author keywords

Gene inhibition; Nucleic acid therapeutics; Reporter genes; siRNA delivery

Indexed keywords

SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY DEVICE; DRUG POTENCY; GENE EXPRESSION; GENE SILENCING; HISTOLOGY; HUMAN; HYPODERMIC NEEDLE; MICRONEEDLE; MICRONEEDLE ARRAY DEVICE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SKIN; TRANSGENE;

EID: 84903837437     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.56     Document Type: Article

References (34)

1. 〈www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM〉.
2. 〈http://rarediseases.info.nih.gov/Resources/Rare-Diseases- Information.aspx〉.
3. Burnett, JC and Rossi, JJ (2012). RNA-based therapeutics: current progress and future prospects. Chem Biol 19: 60-71.
4. Kaspar, RL (2005). Challenges in developing therapies for rare diseases including pachyonychia congenita. J Investig Dermatol Symp Proc 10: 62-66.
5. McLean, WH and Moore, CB (2011). Keratin disorders: from gene to therapy. Hum Mol Genet 20(R2): R189-R197.
6. Rodriguez-Lebron, E and Paulson, HL (2006). Allele-specific RNA interference for neurological disease. Gene Ther 13: 576-581.
7. Kaspar, RL, McLean, WH and Schwartz, ME (2009). Achieving successful delivery of nucleic acids to skin: 6th Annual Meeting of the International Pachyonychia Congenita Consortium. J Invest Dermatol 129: 2085-2087.
8. Leachman, SA, Hickerson, RP, Schwartz, ME, Bullough, EE, Hutcherson, SL, Boucher, KM et al. (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18: 442-446.
9. Gill, HS, Denson, DD, Burris, BA and Prausnitz, MR (2008). Effect of microneedle design on pain in human volunteers. Clin J Pain 24: 585-594.
10. Haq, MI, Smith, E, John, DN, Kalavala, M, Edwards, C, Anstey, A et al. (2009). Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 11: 35-47.
11. Park, KY, Jang, WS, Lim, YY, Ahn, JH, Lee, SJ, Kim, CW et al. (2013). Safety evaluation of stamp type digital microneedle devices in hairless mice. Ann Dermatol 25: 46-53.
12. Gonzalez-Gonzalez, E, Ra, H, Hickerson, RP, Wang, Q, Piyawattanametha, W, Mandella, MJ et al. (2009). siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model. Gene Ther 16: 963-972.
13. Dubuisson, D and Dennis, SG (1977). The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174. (Pubitemid 8234766)
14. Jourdan, D, Ardid, D, Bardin, L, Bardin, M, Neuzeret, D, Lanphouthacoul, L et al. (1997). A new automated method of pain scoring in the formalin test in rats. Pain 71: 265-270. (Pubitemid 27288140)
15. Gonzalez-Gonzalez, E, Speaker, TJ, Hickerson, RP, Spitler, R, Flores, MA, Leake, D et al. (2010). Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Mol Ther 18: 1667-1674.
16. Hengge, UR, Walker, PS and Vogel, JC (1996). Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 97: 2911-2916. (Pubitemid 26197107)
17. Leachman, SA, Hickerson, RP, Hull, PR, Smith, FJ, Milstone, LM, Lane, EB et al. (2008). Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J Dermatol Sci 51: 151-157.
18. González-González, E, Ra, H, Spitler, R, Hickerson, RP, Contag, CH and Kaspar, RL (2010). Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promoters. Gene Ther 17: 1270-1278.
19. Liu, F, Song, Y and Liu, D (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266. (Pubitemid 29359019)
20. Hickerson, RP, Flores, MA, Leake, D, Lara, MF, Contag, CH, Leachman, SA et al. (2011). Use of self-delivery siRNAs to inhibit gene expression in an organotypic pachyonychia congenita model. J Invest Dermatol 131: 1037-1044.
21. Tran, MA, Gowda, R, Sharma, A, Park, EJ, Adair, J, Kester, M et al. (2008). Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res 68: 7638-7649.
22. Lee, WR, Shen, SC, Zhuo, RZ, Wang, KC and Fang, JY (2009). Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin. Hum Gene Ther 20: 580-588.
23. Arora, A, Prausnitz, MR and Mitragotri, S (2008). Micro-scale devices for transdermal drug delivery. Int J Pharm 364: 227-236.
24. Kigasawa, K, Kajimoto, K, Hama, S, Saito, A, Kanamura, K and Kogure, K (2010). Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Int J Pharm 383: 157-160.
25. Broderick, KE, Chan, A, Lin, F, Shen, X, Kichaev, G, Khan, AS et al. (2012). Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. Mol Ther Nucleic Acids 1: e11.
26. Nakai, N, Kishida, T, Shin-Ya, M, Imanishi, J, Ueda, Y, Kishimoto, S et al. (2007). Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf. Gene Ther 14: 357-365. (Pubitemid 46231929)
27. Golzio, M, Mazzolini, L, Ledoux, A, Paganin, A, Izard, M, Hellaudais, L et al. (2007). In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther 14: 752-759. (Pubitemid 46585656)
28. Chong, RH, Gonzalez-Gonzalez, E, Lara, MF, Speaker, TJ, Contag, CH, Kaspar, RL et al. (2013). Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. J Control Release 166: 211-219.
29. González-González, E, Kim, YC, Speaker, TJ, Hickerson, RP, Spitler, R, Birchall, JC et al. (2011). Visualization of plasmid delivery to keratinocytes in mouse and human epidermis. Sci Rep 1: 158.
30. Lara, MF, González-González, E, Speaker, TJ, Hickerson, RP, Leake, D, Milstone, LM et al. (2012). Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays. Hum Gene Ther 23: 816-823.
31. Cao, T, Longley, MA, Wang, XJ and Roop, DR (2001). An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J Cell Biol 152: 651-656. (Pubitemid 34280246)
32. Wong, P, Domergue, R and Coulombe, PA (2005). Overcoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic mice. Mol Cell Biol 25: 197-205. (Pubitemid 40039811)
33. Schindelin, J, Arganda-Carreras, I, Frise, E, Kaynig, V, Longair, M, Pietzsch, T et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.
34. Thévenaz, P, Ruttimann, UE and Unser, M (1998). A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 7: 27-41. (Pubitemid 128745320)